Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2005 | 1 |
2006 | 4 |
2007 | 1 |
2008 | 2 |
2022 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Management and Long-Term Follow-Up of Hyperparathyroidism in Multiple Endocrine Neoplasia Type 1: Single Center Experience.
J Clin Med. 2022 Apr 1;11(7):1967. doi: 10.3390/jcm11071967.
J Clin Med. 2022.
PMID: 35407574
Free PMC article.
The effect of low dose hormone therapy on mammographic breast density.
Christodoulakos GE, Lambrinoudaki IV, Vourtsi AD, Vlachou S, Creatsa M, Panoulis KP, Botsis D.
Christodoulakos GE, et al. Among authors: vlachou s.
Maturitas. 2006 Apr 20;54(1):78-85. doi: 10.1016/j.maturitas.2005.08.012. Epub 2005 Sep 29.
Maturitas. 2006.
PMID: 16198519
Clinical Trial.
Item in Clipboard
CYP A-204C polymorphism is associated with subclinical atherosclerosis in postmenopausal women.
Lambrinoudaki IV, Kaparos GI, Vlachou SA, Stamatelopoulos KS, Georgiopoulos GA, Sergentanis TN, Panoulis CP, Christodoulakos GE, Alexandrou AP, Kouskouni EE, Creatsa MG, Papamichael CM.
Lambrinoudaki IV, et al. Among authors: vlachou sa.
Menopause. 2008 Nov-Dec;15(6):1163-8. doi: 10.1097/gme.0b013e31817727c3.
Menopause. 2008.
PMID: 18665040
Item in Clipboard
Circulating leptin and ghrelin are differentially influenced by estrogen/progestin therapy and raloxifene.
Lambrinoudaki IV, Christodoulakos GE, Economou EV, Vlachou SA, Panoulis CP, Alexandrou AP, Kouskouni EE, Creatsas GC.
Lambrinoudaki IV, et al. Among authors: vlachou sa.
Maturitas. 2008 Jan 20;59(1):62-71. doi: 10.1016/j.maturitas.2007.10.003.
Maturitas. 2008.
PMID: 18164562
Clinical Trial.
Item in Clipboard
Endogenous sex hormones and risk factors for atherosclerosis in healthy Greek postmenopausal women.
Lambrinoudaki I, Christodoulakos G, Rizos D, Economou E, Argeitis J, Vlachou S, Creatsa M, Kouskouni E, Botsis D.
Lambrinoudaki I, et al. Among authors: vlachou s.
Eur J Endocrinol. 2006 Jun;154(6):907-16. doi: 10.1530/eje.1.02167.
Eur J Endocrinol. 2006.
PMID: 16728552
Item in Clipboard
Differential effect of hormone therapy and tibolone on lipids, lipoproteins, and the atherogenic index of plasma.
Christodoulakos GE, Lambrinoudaki IV, Economou EV, Papadias C, Panoulis CP, Kouskouni EE, Vlachou SA, Creatsas GC.
Christodoulakos GE, et al. Among authors: vlachou sa.
J Cardiovasc Pharmacol. 2006 Apr;47(4):542-8. doi: 10.1097/01.fjc.0000211747.16573.d5.
J Cardiovasc Pharmacol. 2006.
PMID: 16680067
Clinical Trial.
Item in Clipboard
Circulating chemoattractants RANTES, negatively related to endogenous androgens, and MCP-1 are differentially suppressed by hormone therapy and raloxifene.
Christodoulakos GE, Lambrinoudaki IV, Economou EV, Papadias C, Vitoratos N, Panoulis CP, Kouskouni EE, Vlachou SA, Creatsas GC.
Christodoulakos GE, et al. Among authors: vlachou sa.
Atherosclerosis. 2007 Jul;193(1):142-50. doi: 10.1016/j.atherosclerosis.2006.05.045. Epub 2006 Jul 13.
Atherosclerosis. 2007.
PMID: 16842799
Clinical Trial.
Item in Clipboard
Cite
Cite